生物胶吊带技术在动脉粥样硬化性椎基底动脉所致三叉神经痛微血管减压术中的应用
该回顾性研究纳入22例动脉粥样硬化性椎基底动脉(aVBA)相关三叉神经痛患者,行生物胶吊带技术微血管减压术。术后20例(91%)疼痛完全缓解,2例(9%)部分缓解;随访18-27个月,2例需卡马西平控制。1例出现术后听力下降,2个月内完全恢复。作者认为该技术简单、省时省空间,可作为替代减压方法。
要点
- aVBA相关三叉神经痛行生物胶吊带技术微血管减压,术后91%完全缓解。
- 随访18-27个月,部分缓解者需卡马西平维持,无严重并发症。
- 该技术优势为简单、省时省空间,但需更大样本对照研究验证。
核心结论
- 生物胶吊带技术微血管减压可为aVBA相关三叉神经痛提供替代减压方法,但需更大样本和对照组研究证实其高效性。
研究设计与样本
- 回顾性研究,纳入2016年9月至2017年6月连续22例接受生物胶吊带技术微血管减压的aVBA相关三叉神经痛患者。
主要发现
- 术中aVBA为直接或间接责任血管者22例,合并小脑上动脉12例、静脉1例、小脑前下动脉6例。
- 术后三叉神经痛完全缓解20例(91%),部分缓解2例(9%)。
- 随访18-27个月,2例部分缓解者疼痛加重,卡马西平可缓解。
- 术后即刻听力下降1例,2个月内完全恢复。
临床怎么用
- 对于aVBA相关三叉神经痛,可考虑采用生物胶吊带技术行微血管减压,以简化操作并减少空间和时间需求。
局限性
- 回顾性研究,样本量小(22例),无对照组,随访时间有限(18-27个月),需进一步大样本对照研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Microvascular decompression (MVD) is the most definitive surgical treatment for trigeminal neuralgia (TN). In the case in which an atherosclerotic vertebrobasilar artery (aVBA) offends the trigeminal nerve, the postoperative outcomes have been reported to be less satisfactory in terms of symptom recurrence and complications. In this study, the authors present their experience using a biomedical sling for MVD in patients with aVBA-associated TN. METHODS: A retrospective study of 22 consecutive patients who underwent the biomedical glue sling technique in MVD for TN with aVBA was conducted between September 2016 and June 2017. RESULTS: Intraoperatively, aVBA was regarded as the direct or indirect offending vessel in 22 patients. In addition to aVBA, other vessels involved in neurovascular conflict included superior cerebellar artery in 12 patients, veins in 1, and anterior inferior cerebellar artery in 6. All 22 patients underwent the biomedical glue sling technique. Postoperatively, TN was completely resolved in 20 (91%) patients and partially relieved in 2 (9%) patients. During the follow-up period of 18-27 months, pain developed severely in those 2 patients but could be relieved with carbamazepine. As for complications, postoperative hypoacusia occurred immediately in 1 case, with complete resolution in 2 months. CONCLUSIONS: The biggest advantage of the biomedical glue sling technique is its simplicity in achieving complete decompression, requiring relatively less space and time. Because the outcome of traditional MVD regarding aVBA-associated TN remains controversial, the biomedical glue sling technique in MVD provides an alternative decompressive method for patients with TN associated with aVBA. However, further studies with a larger series and control group are required to prove the high effectiveness of this method.
引用
- Liu J, Chen Z, Feng T, et al. Biomedical Glue Sling Technique in Microvascular Decompression for Trigeminal Neuralgia Caused by Atherosclerotic Vertebrobasilar Artery: A Description of Operative Technique and Clinical Outcomes. World Neurosurg. 2019. PMID: 30954750. doi:10.1016/j.wneu.2019.03.289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。